|
| Validation of RIPK2 as a Small Molecule Drug Target for Lung Cancer Treatment |
2019 (Cycle 30) |
$118,350 |
| Cancer |
Dissertation Awards |
|
| Early Diagnosis/Pathogenesis of Tobacco-Related Lung Disease |
2014 (Cycle 23) |
$675,093 |
| Early Diagnosis/Pathogenesis |
Research Project Awards |
|
| NOVEL nAChR MODULATORS FOR TREATING NICOTINE ADDICTION |
2012 (Cycle 21) |
$27,273 |
| Disparities /Prevention/ Cessation/ Nicotine Dependence |
Postdoctoral Fellowship Awards |
|
| Oxidative Stress/Inflammation in Pulmonary Disease |
2012 (Cycle 21) |
$409,427 |
| Early Diagnosis/Pathogenesis |
Exploratory/Developmental Award |
|
| Leveraging Adjuvants for Improved Nicotine Vaccines |
2011 (Cycle 20) |
$421,413 |
| Tobacco-Use Prevention and Cessation |
Exploratory/Developmental Award |
|
| SOX-2 knockdown in stem cells prevents lung tumor recurrence |
2010 (Cycle 19) |
$473,879 |
| Cancer |
Exploratory/Developmental Award |
|
| Enhancing mTOR-targeted lung cancer therapy |
2010 (Cycle 19) |
$473,879 |
| Cancer |
Exploratory/Developmental Award |
|
| S-Nitrosylation of DNMTs in epigenetic regulation of tumors |
2018 (Cycle 27) |
$1,448,303 |
| Cancer |
High Impact Research Project Award |
|
| Effects of nicotine e-cigarette self-administration on addiction |
2018 (Cycle 27) |
$459,503 |
| Neuroscience of Nicotine Addiction and Treatment |
High Impact Research Project Award |
|
| Nicotine Self-Administration in an Animal Model |
2008 (Cycle 17) |
$720,434 |
| Nicotine Dependence |
Research Project Awards |
|
| Modulating TLR9 Activation for Lung Cancer Therapy |
2007 (Cycle 16) |
$246,467 |
| Cancer |
Research Project Awards |
|
| Unraveling lung cancer signaling pathways |
2006 (Cycle 15) |
$780,780 |
| Cancer |
Research Project Awards |
|
| Conformationally constrained nicotine vaccines |
2005 (Cycle 14) |
$778,921 |
| Nicotine Dependence |
Research Project Awards |
|
| Development of nicotine withdrawal measures |
2005 (Cycle 14) |
$91,173 |
| Nicotine Dependence |
Inno Dev & Exp Awards (IDEAS) |
|
| Bupropion and nicotine dependence: behavior & neurochemisty |
2005 (Cycle 14) |
$37,500 |
| Nicotine Dependence |
Postdoctoral Fellowship Awards |
|
| Activation of Bnip3 in tobacco-induced heart disease |
2005 (Cycle 14) |
$134,074 |
| Cardiovascular Disease |
New Investigator Awards |
|
| Defining mutagenesis pathways in tobacco-related cancer |
2005 (Cycle 14) |
$58,993 |
| Cancer |
Dissertation Awards |
|
| Tobacco use and atherosclerosis protection by paraoxonase |
2004 (Cycle 13) |
$729,234 |
| Cardiovascular Disease |
Research Project Awards |
|
| Neurobiological substrates of nicotine addiction |
2003 (Cycle 12) |
$723,613 |
| Nicotine Dependence |
Research Project Awards |
|
| Nicotine self-administration in an animal model |
2003 (Cycle 12) |
$660,156 |
| Nicotine Dependence |
Research Project Awards |
|
| Structure of CYP2A6: the principal nicotine oxidase |
2003 (Cycle 12) |
$75,060 |
| General Biomedical Science |
Postdoctoral Fellowship Awards |
|
| Focal adhesion kinase regulation of Cox-2 in lung cancer |
2003 (Cycle 12) |
$74,520 |
| Cancer |
Postdoctoral Fellowship Awards |
|
| Novel DNA vaccines for the treatment of lung cancer |
2003 (Cycle 12) |
$783,900 |
| Cancer |
Research Project Awards |
|
| Neuroadaptations underlying nicotine dependence |
2002 (Cycle 11) |
$60,379 |
| Nicotine Dependence |
Postdoctoral Fellowship Awards |
|
| Immunopharmacotherapy as a treatment for nicotine addiction |
2002 (Cycle 11) |
$515,270 |
| Nicotine Dependence |
Research Project Awards |
|
| Regulation of integrin activation by calcineurin |
2002 (Cycle 11) |
$68,437 |
| Cardiovascular Disease |
Postdoctoral Fellowship Awards |
|
| Inflammation, innate immunity, TLRs, and atherosclerosis |
2002 (Cycle 11) |
$697,650 |
| Cardiovascular Disease |
Research Project Awards |
|
| Tobacco smoke, inflammation & atherosclerosis |
2001 (Cycle 10) |
$754,932 |
| Cardiovascular Disease |
Research Project Awards |
|
| Neurobiological substrates of nicotine addiction |
2001 (Cycle 10) |
$402,852 |
| Nicotine Dependence |
Research Project Awards |
|
| Neurobehavioral consequences of adolescent nicotine exposure |
2001 (Cycle 10) |
$630,710 |
| Nicotine Dependence |
Research Project Awards |
|
| Nicotine dependence & schizophrenia |
2001 (Cycle 10) |
$75,600 |
| Nicotine Dependence |
Postdoctoral Fellowship Awards |
|
| Neurobehavioral consequences of adolescent nicotine exposure |
2000 (Cycle 9) |
$120,000 |
| Nicotine Dependence |
Research Project Awards |
|
| Macrophage function in atherosclerosis |
2000 (Cycle 9) |
$709,200 |
| Cardiovascular Disease |
Research Project Awards |
|
| Novel DNA vaccines for the treatment of lung cancer |
2000 (Cycle 9) |
$1,063,300 |
| Cancer |
Research Project Awards |
|
| Cell Adhesion Receptors in Atherogenesis |
1994 (Cycle 3) |
$391,252 |
| Cardiovascular Disease |
Research Project Awards |
|
| Sites of Chemoattractant Receptor Interaction with G Protein |
1994 (Cycle 3) |
$720,174 |
| Pulmonary Disease |
Research Project Awards |
|
| Functional Synthetic Peptide Mimics of Apolipoprotein E |
1994 (Cycle 3) |
$653,578 |
| Cardiovascular Disease |
Research Project Awards |
|
| Role of aV Integrins in Malignancy of Tobacco/Induced Tumors |
1994 (Cycle 3) |
$485,909 |
| Cancer |
Research Project Awards |
|
| Activated Protein C in Smokers Thrombosis |
1993 (Cycle 2) |
$347,737 |
| Cardiovascular Disease |
Research Project Awards |
|
| Regulation of Oxidant Production in Activated Phagocytes |
1993 (Cycle 2) |
$540,379 |
| Pulmonary Disease |
Research Project Awards |
|
| Selective Lung Tumor Inhibition With 4-Ipomeanol Analogs |
1993 (Cycle 2) |
$126,499 |
| Cancer |
Inno Dev & Exp Awards (IDEAS) |
|
| Effect of Nicotine on Fibrinolytic Responsiveness in Vivo |
1993 (Cycle 2) |
$69,941 |
| Cardiovascular Disease |
Inno Dev & Exp Awards (IDEAS) |
|
| Interaction of Complement C4b-Binding Protein with Protein B |
1992 (Cycle 1) |
$616,016 |
| General Biomedical Science |
Research Project Awards |
|
| Factors Required for K-RAS 4B Membrane Association/Activity |
1992 (Cycle 1) |
$600,414 |
| General Biomedical Science |
Research Project Awards |
|
| The Accumbens: A Critical Brain Site for Nicotine Craving |
1992 (Cycle 1) |
$532,964 |
| Nicotine Dependence |
Research Project Awards |
|
| Factors Required for K-RAS 4B Membrane Association & Activity |
1992 (Cycle 1) |
$164,736 |
| General Biomedical Science |
New Investigator Awards |
|
| Hormone replacement therapy, smoking & lipoprotein oxidation |
1998 (Cycle 7) |
$385,808 |
| Cardiovascular Disease |
Research Project Awards |
|
| Neurobiological substrates of nicotine addiction |
1998 (Cycle 7) |
$742,393 |
| Nicotine Dependence |
Research Project Awards |
|
| The effect of nicotine and cigarette smoke on respiration |
1998 (Cycle 7) |
$130,177 |
| Epidemiology |
Inno Dev & Exp Awards (IDEAS) |
|
| Developing treatments that lower blood cholesterol levels |
1997 (Cycle 6) |
$746,536 |
| Cardiovascular Disease |
Research Project Awards |
|
| Brain wave assessment of tobacco cessation readiness |
1997 (Cycle 6) |
$115,487 |
| Nicotine Dependence |
New Investigator Awards |
|
| Electrophysiological Effects of Perinatal Nicotine Exposure |
1995 (Cycle 4) |
$446,225 |
| General Biomedical Science |
Research Project Awards |
|
| Membrane Signaling Pathways of RAS/RAB Proteins |
1995 (Cycle 4) |
$574,559 |
| Cancer |
Research Project Awards |
|
| Vitronectin in Cardiovascular Disease |
1995 (Cycle 4) |
$352,644 |
| Cardiovascular Disease |
New Investigator Awards |
|
| Integrin Cytoplasmic Domains and Ligand Affinity Modulation |
1994 (Cycle 3) |
$522,649 |
| Cardiovascular Disease |
Research Project Awards |